IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes.
Amendolara R, D'Onofrio L, Sessa RL, Di Giulio S, Mignogna C, Coraggio L, Schirano R, Zampetti S, Malandrucco I, Pozzilli P, Giannini G, Maddaloni E, Buzzetti R.
Amendolara R, et al.
J Clin Endocrinol Metab. 2025 Jan 6:dgaf001. doi: 10.1210/clinem/dgaf001. Online ahead of print.
J Clin Endocrinol Metab. 2025.
PMID: 39760686